Stroke in Coronavirus Disease 2019: A Systematic Review
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background and Purpose Various neurological findings including stroke in patients with coronavirus disease 2019 (COVID-19) have been described, although no clarity exists regarding the nature and pattern of this association. This systematic review aims to report the characteristics of stroke in patients with COVID-19. Methods Three authors independently searched Web of Science, Embase, Scopus, and PubMed starting from inception up to May 22, 2020. The data for individual patients was extracted where available from published reports including clinical and laboratory parameters and analysed for any significant associations between variables. Results We identified 30 relevant articles involving 115 patients with acute or subacute stroke with COVID-19. The mean±standard deviation age was 62.5±14.5 years. Stroke was ischemic in majority of the patients (101 [87.8%]). Hypertension (42 [42%]), dyslipidaemia (24 [26.1%]), and diabetes (23 [23.2%]) were the major vascular risk factors. Most of the patients (80 [85.1%]) had COVID-19 symptoms at the time of stroke with a median interval of 10 days to stroke from the diagnosis of COVID-19. Three-fourths (86 [74.8%]) of the patients were critically ill which frequently delayed the diagnosis of stroke. High levels of D-dimer, and ferritin were observed in these patients. Patients with COVID-19 and stroke had a high mortality (47.9%). Factors associated with mortality were intensive care unit admission, having two or more vascular risk factors, particularly smoking and high levels of D-dimer, C-reactive protein, and lactate dehydrogenase. Conclusions The association between stroke and COVID-19 is probably multifactorial including an amalgamation of traditional vascular risk factors, proinflammatory and a prothrombotic state. Prospectively collected data is required in the future to confirm this hypothesis.
Abstract
Background and Purpose Various neurological findings including stroke in patients with coronavirus disease 2019 (COVID-19) have been described, although no clarity exists regarding the nature and pattern of this association. This systematic review aims to report the characteristics of stroke in patients with COVID-19. Methods Three authors independently searched Web of Science, Embase, Scopus, and PubMed starting from inception up to May 22, 2020. The data for individual patients was extracted where available from published reports including clinical and laboratory parameters and analysed for any significant associations between variables. Results We identified 30 relevant articles involving 115 patients with acute or subacute stroke with COVID-19. The mean±standard deviation age was 62.5±14.5 years. Stroke was ischemic in majority of the patients (101 [87.8%]). Hypertension (42 [42%]), dyslipidaemia (24 [26.1%]), and diabetes (23 [23.2%]) were the major vascular risk factors. Most of the patients (80 [85.1%]) had COVID-19 symptoms at the time of stroke with a median interval of 10 days to stroke from the diagnosis of COVID-19. Three-fourths (86 [74.8%]) of the patients were critically ill which frequently delayed the diagnosis of stroke. High levels of D-dimer, and ferritin were observed in these patients. Patients with COVID-19 and stroke had a high mortality (47.9%). Factors associated with mortality were intensive care unit admission, having two or more vascular risk factors, particularly smoking and high levels of D-dimer, C-reactive protein, and lactate dehydrogenase. Conclusions The association between stroke and COVID-19 is probably multifactorial including an amalgamation of traditional vascular risk factors, proinflammatory and a prothrombotic state. Prospectively collected data is required in the future to confirm this hypothesis.
참고문헌 (31)
- "Levels of Evidence" (2009)[URL]
- Beyrouti R, "Characteristics of ischaemic stroke associated with COVID-19", J Neurol Neurosurg Psychiatry, 91, pp.889~891 (2020)
- Viguier A, "Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection", J Neuroradiol, 47, pp.393~394 (2020)
- Avula A, "COVID-19 presenting as stroke", Brain Behav Immun, 87, pp.115~119 (2020)
- Zhou B, "A case of coronavirus disease 2019 with concomitant acute cerebral infarction and deep vein thrombosis", Front Neurol, 11, pp.296~ (2020)
- Sharifi-Razavi A, "COVID-19 and intracerebral haemorrhage: causative or coincidental?", New Microbes New Infect, 35, pp.100669~ (2020)
- Zhang Y, "Coagulopathy and antiphospholipid antibodies in patients with Covid-19", N Engl J Med, 382, pp.e38~ (2020)
- Morassi M, "Stroke in patients with SARS-CoV-2 infection : case series", J Neurol, 267, pp.2185~2192 (2020)
- Helms J, "High risk of thrombosis in patients with severe SARS-CoV-2 infection : a multicenter prospective cohort study", Intensive Care Med, 46, pp.1089~1098 (2020)
- González-Pinto T, "Emergency room neurology in times of COVID-19 : malignant ischaemic stroke and SARS-CoV-2 infection", Eur J Neurol, 27, pp.e35~e36 (2020)
- Oxley TJ, "Large-vessel stroke as a presenting feature of Covid-19in the young", N Engl J Med, 382, pp.e60~ (2020)
- Klok FA, "Incidence of thrombotic complications in critically ill ICU patients with COVID-19", Thromb Res, 191, pp.145~147 (2020)
- Al Saiegh F, "Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke", J Neurol Neurosurg Psychiatry, 91, pp.846~848 (2020)
- Zhai P, "The impact of COVID-19 on ischemic stroke", Diagn Pathol, 15, pp.78~ (2020)
- Yaghi S, "SARS-CoV-2 and stroke in a New York Healthcare System", Stroke, 51, pp.2002~2011 (2020)
- Valderrama EV, "Severe acute respiratory syndrome coronavirus 2 infection and ischemic stroke", Stroke, 51, pp.e124~e127 (2020)
- He J, "Diagnosis and treatment of an elderly patient with secondary cerebral infarction caused by COVID-19", Nan Fang Yi Ke Da Xue Xue Bao, 40, pp.351~352 (2020)
- Li Y, "Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study", Stroke Vasc Neurol (2020)
- Mao L, "Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China", JAMA Neurol, 77, pp.1~9 (2020)
- Helms J, "Neurologic features in severe SARS-CoV-2infection", N Engl J Med, 382, pp.2268~2270 (2020)
- Lodigiani C, "Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy", Thromb Res, 191, pp.9~14 (2020)
- TunÇ A, "Coexistence of COVID-19 and acute ischemic stroke report of four cases", J Clin Neurosci, 77, pp.227~229 (2020)
- Muhammad S, "Letter to editor : severe brain haemorrhage and concomitant COVID-19 infection : a neurovascular complication of COVID-19", Brain Behav Immun, 87, pp.150~151 (2020)
- Garaci F, "Venous cerebral thrombosis in COVID-19 patient", J Neurol Sci, 414, pp.116871~ (2020)
- Moshayedi P, "Triage of acute ischemic stroke in confirmed COVID-19 : large vessel occlusion associated with coronavirus infection", Front Neurol, 11, pp.353~ (2020)
- Zulfiqar AA, "Immune thrombocytopenic purpura in a patient with COVID-19", N Engl J Med, 382, pp.e43~ (2020)
- Chen S, "COVID-19with acute cerebral infarction : one case report", Chin J Neurol, 53, pp.309~311 (2020)
- Co CO, "Intravenous thrombolysis for stroke in a COVID-19 positive Filipino patient, a case report", J Clin Neurosci, 77, pp.234~236 (2020)
- Deliwala S, "Encephalopathy as the sentinel sign of a cortical stroke in a patient infected with coronavirus disease-19(COVID-19)", Cureus, 12, pp.e8121~ (2020)
- Goldberg MF, "Cerebrovascular disease in COVID-19", AJNR Am J Neuroradiol, 41, pp.1170~1172 (2020)
- Dahl-Cruz F, "Cerebral venous thrombosis and SARS-CoV-2 infection", Rev Neurol, 70, pp.391~392 (2020)